Core Viewpoint - The Thai FDA is enhancing oversight of dietary supplement advertising to combat exaggerated health claims and misleading marketing practices across various channels, reflecting increasing regulatory scrutiny in the global dietary supplements market [1][2]. Regulatory Actions - The Thai FDA is collaborating with multiple agencies to improve enforcement and consumer protection, focusing on advertising compliance and product transparency [2]. - An integrated enforcement approach has been adopted, expanding collaboration with partner organizations to monitor misleading health product advertising, particularly for dietary supplements [3]. Compliance and Enforcement - Authorities are prioritizing cases where advertising misleads consumers regarding product benefits, ingredients, or outcomes, especially in areas like weight loss and beauty benefits, which have historically seen high non-compliance [4]. - Previous enforcement efforts indicate that a significant portion of problematic advertising is related to dietary supplements, often promoted through broadcast and digital channels [4]. Misleading Claims - Recent studies reveal that over 80% of supplement listings on Thai e-commerce platforms contain unapproved or misleading health claims [5]. - Thai regulations broadly define health claims, requiring regulatory approval and scientific evidence for any statement linking a product to health outcomes, including indirect wording like "supports" or "helps" [5]. Implications for Retailers - The crackdown on misleading claims poses compliance risks for retailers and distributors, particularly in cross-border e-commerce, necessitating accurate and substantiated product claims aligned with local regulations [6][7]. - Businesses must ensure that all product claims are compliant with Thai regulations to avoid penalties and maintain consumer trust [7].
Thailand dietary supplement advertising crackdown targets retailers
Yahoo Finance·2026-03-24 10:05